|
|
|
|
Suppliers for
Linifanib
|
Properties | | CAS |
796967-16-3 | | Formula |
C21H18FN5O |
|
|
8 Registered suppliers
Molecular Formula: C21H18FN5O
Molecular Weight: 375.405
Molecular Formula: C21H18FN5O
Molecular Weight: 375.405
Molecular Formula: C21H18FN5O
Molecular Weight: 375.405
Molecular Formula: C21H18FN5O
Molecular Weight: 375.405
Molecular Formula: C21H18FN5O
Molecular Weight: 375.405
Description : Description of Linifanib: Linifanib is an orally bioavailable, small-molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Linifanib inhibits members of the vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) receptor families; it exhibits much less activity against unrelated RTKs, soluble tyrosine kinases, or serine/threonine kinases. This agent does not have a general antiproliferative effect due to its high dose requirement. However, linifanib may exhibit potent antiproliferative and apoptotic effects on tumor cells whose proliferation is dependent on mutant kinases, such as fms-related tyrosine kinase receptor-3 (FLT3). - Molecular Weight :375.407
Molecular Formula : C21H18FN5O Canonical SMILES : CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N
InChI :
InChI=1S/C21H18FN5O/c1-12-5-10-16(22)18(11-12)25-21(28)24-14-8-6-13(7-9-14)15-3-2-4-17-19(15)20(23)27-26-17/h2-11H,1H3,(H3,23,26,27)(H2,24,25,28)
InChIKey :
MPVGZUGXCQEXTM-UHFFFAOYSA-N
Synonyms :
ABT869; ABT 869; ABT-869; Linifanib
More details are to be found here
More details are to be found here
More details are to be found here
Detailed information on the suppliers of
Linifanib |
Properties:
... more properties and specification on Linifanib
|
|
Privileged suppliers
Last update 2024-06-03
|
details
details